Advanced search
Publication Cover
Cancer Biology & Therapy Volume 17, 2016 - Issue 6
Submit an article Journal homepage
835
Views
0
CrossRef citations to date
0
Altmetric
Journal Club

YAP controls transcriptional elongation through CKD9 recruitment for proximal pause release: “Hippo-thetical”, new therapeutic targets?

Fiorina KyritsiGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Douglas K. PriceGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
&
William D. FiggGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected]
Pages 592-594 | Received 04 May 2016, Accepted 11 Apr 2016, Published online: 20 May 2016

References

  • Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 2003; 114:457-67; PMID:12941274; http://dx.doi.org/10.1016/S0092-8674(03)00557-9
  • Zhao B, Li L, Lei Q, Guan K-L. The Hippo-YAP pathway in organ size control and tumorigenesis:an updated version. Gen Dev 2010; 24:62-874; PMID:20439427; http://dx.doi.org/10.1101/gad.1909210
  • Galli GG, Carrara M, Yuan WC, Valdes-Quezada C, Gurung B, Pepe-Mooney B, Zhang T, Geeven G, Gray NS, de Laat W, et al. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell 2015; 60(2):328-37; 2015 Sep 30: pii: S1097-2765(15)00697-8; PMID:26439301; http://dx.doi.org/10.1016/j.molcel.2015.09.001
  • Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008; 22:1962-71; PMID:18579750; http://dx.doi.org/10.1101/gad.1664408
  • Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA. Super-enhancers in the control of cell identity and disease. Cell 2013; 155:934-47; PMID:24119843; http://dx.doi.org/10.1016/j.cell.2013.09.053
  • Plouffe SW, Hong AW, Guan K-L. Disease implications of the Hippo/YAP pathway. Trends Mol Med April 2015; 21(4):212-22; PMID:25702974; http://dx.doi.org/10.1016/j.molmed.2015.01.003
  • Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LSB, Abujarour R, et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 2010; 24:1106-18; PMID:20516196; http://dx.doi.org/10.1101/gad.1903310
  • Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 2012; 13:720-31; PMID:22986266; http://dx.doi.org/10.1038/nrg3293
  • Wade JT, Struhl K. The transition fron transcriptional initiation to elongation. Curr Opin Genet Dev 2008; 18:130-6; PMID:18282700; http://dx.doi.org/10.1016/j.gde.2007.12.008
  • Malik S, Roeder RG. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 2010; 11:761-72; PMID:20940737; http://dx.doi.org/10.1038/nrg2901
  • Wang G, Balamotis MA, Stevens JL, Yamaguchi Y, Handa H, Berk AJ. Mediator requirement for both recruitment and postrecruitement steps in transcription initiation. Mol Cell 2005; 17:683-94; PMID:15749018; http://dx.doi.org/10.1016/j.molcel.2005.02.010
  • Donner AJ, Ebmeier CC, Taajes DJ, Espinosa JM. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat Struct Mol Biol 2010; 17:194-201; PMID:20098423; http://dx.doi.org/10.1038/nsmb.1752
  • Ehmer U, Sage J. Control of proliferation and cancer growth by the Hippo signaling pathway. Mol Cancer Res. 2016 Feb;14(2):127-40; PMID:26432795; http://dx.doi.org/10.1158/1541-7786.MCR-15-0305
  • Butler JE, Kadonaga JT. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 2002; 16:2583-92; PMID:12381658; http://dx.doi.org/10.1101/gad.1026202
  • Park HW, Guan K-L. The regulation of Hippo pathway and implications for anticancer drug development. Trends Pharmacol Sci 2013; 34(10):581-9; PMID:24051213; http://dx.doi.org/10.1016/j.tips.2013.08.006
  • Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan D. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 2012; 26:1300-5; PMID:22677547; http://dx.doi.org/10.1101/gad.192856.112

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.